Expert in Cardiogenetics & Precision Medicine
Advancing personalized care and innovative research for patients with inherited heart diseases.
Clinical Excellence
Managed over 5,000 patient cases in the fields of cardiogenetics and oncogenetics
Affiliated Institutions and Collaborations
About Dr. Mohamed El Hachmi
Dr. Mohamed El Hachmi is a Cardiogeneticist specializing in Precision Medicine, with dual PhDs from Sapienza University of Rome and Paris Cité University. His research focuses on rare inherited heart diseases, with particular expertise in Hypertrophic Cardiomyopathy (HCM), Vascular Ehlers-Danlos Syndrome (vEDS), and Cardiac Amyloidosis (ATTR).
Dual PhD
Sapienza University of Rome & Paris Cité University
Executive Board Member
European Board of Medical Genetics (EBMG)
Former Cardiogeneticist
Hôpital Européen Georges Pompidou, Paris
Research Focus Areas
Hypertrophic Cardiomyopathy (HCM)
HCMLeading the GEREMY Registry for genetic profiling and precision treatment eligibility in HCM patients. Developing risk stratification models based on genetic variants.
For Patients
HCM causes the heart muscle to thicken, making it harder to pump blood. We're studying genetic factors to improve treatment options and predict who may develop symptoms.
Inherited Dilated Cardiomyopathies and Neuromuscular Disorders: Genetics, Risk Stratification, and Clinical Management
DCMComprehensive research on genetic and phenotypic determinants of disease progression in dilated cardiomyopathy, with specialized focus on laminopathies and neuromuscular cardiomyopathies.
For Patients
We study inherited forms of dilated cardiomyopathy to identify high-risk patients early and develop personalized treatment strategies to prevent complications.
Arrhythmogenic Cardiomyopathy (ACM)
ACMExpert diagnosis, risk stratification and management of this complex disease using multidisciplinary approach integrating clinical assessment, advanced imaging and cardiovascular genetics.
For Patients
ACM is a rare inherited heart condition that can cause dangerous heart rhythms. We work to identify patients at risk and provide personalized care to prevent sudden cardiac events.
Polygenic Risk Scores (PRS) in Cardiovascular Disease
PRSExpert Lead: Dr. El Hachmi – Genetic Counselling & PRS Specialist. Recognized expertise in integrating PRS into personalized cardiovascular prevention, focusing on atrial fibrillation, coronary artery disease, and hypercholesterolemia.
For Patients
If you have a family history of cardiovascular disease or have received an early diagnosis, PRS testing may help you understand your genetic risk profile and support more personalized treatment decisions.
Latest Publications
Irbesartan and celiprolol combination therapy for vascular Ehlers-Danlos syndrome
Circulation
Read more →French Hypertrophic Cardiomyopathy Genetic Registry: 5-year outcomes and risk stratification
International Journal of Cardiology
Read more →Genetic Testing Score for Arrhythmogenic Left Ventricular Cardiomyopathy
Circulation: Genomic and Precision Medicine
Read more →Seeking Collaborative Research Opportunities
Dr. El Hachmi is actively looking for research partners in multicenter studies, cohort data sharing, and genetic screening programs for inherited cardiac disorders.